Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research

被引:165
作者
Larsen, MO [1 ]
Rolin, B
机构
[1] Novo Nordisk AS, Dept Pharmacol Res 1, Malov, Denmark
[2] Novo Nordisk AS, Dept Pharmacol Res 3, Malov, Denmark
关键词
animal model; comparative physiology; large animal model; pig; streptozotocin; type; 1; diabetes;
D O I
10.1093/ilar.45.3.303
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 [兽医学];
摘要
Animal models of type 1 diabetes remain essential tools for investigation of the etiology and pathogenesis of the disease and, importantly, for the development of effective new treatments. Although a range of well-characterized and widely used models of type 1 diabetes in rodents are currently available, large animal models are a valuable complement to rodent models for both physiological and practical reasons. The pig is very useful in many aspects as a model for human physiology and pathophysiology because many organ systems of this species, as well as physiological and pathophysiological responses, resemble those of the human. The Gottingen minipig is particularly suitable for long-term studies because of its inherent small size and ease of handling, even at full maturity. Of particular relevance to the field of type 1 diabetes are the many similarities evident between humans and pigs with regard to pharmacokinetics of compounds after subcutaneous administration, structure and function of the gastrointestinal tract, morphology of the pancreas, and the overall metabolic status of the two species. Because spontaneous type 1-like diabetes is very rare in pigs, a model of the condition must be induced experimentally, either surgically or chemically. This process is discussed, and the use of the pig as a model in islet transplantation and diabetic complications is briefly summarized.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 168 条
[1]
*ADA, 1998, CLIN ED SER, P1
[2]
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men [J].
Agerso, H ;
Jensen, LB ;
Elbrond, B ;
Rolan, P ;
Zdravkovic, M .
DIABETOLOGIA, 2002, 45 (02) :195-202
[4]
Alberti K.G., 1999, DIAGNOSIS CLASSIFICA
[5]
EFFECT OF FASTING AND GLUCOSE LOAD ON INSULIN-SECRETION AND STAUB-TRAUGOTT PHENOMENON IN PIGS [J].
ANDERSON, DM .
JOURNAL OF ENDOCRINOLOGY, 1973, 58 (03) :613-625
[6]
INTRAVENOUS GLUCOSE TOLERANCE TEST IN PIG [J].
ANDERSON, DM ;
ELSLEY, FWH .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1970, 55 (02) :104-&
[7]
Genetic polymorphism of the swine major histocompatibility complex (SLA) class I genes, SLA-1, -2 and -3 [J].
Ando, A ;
Kawata, H ;
Shigenari, A ;
Anzai, T ;
Ota, M ;
Katsuyama, Y ;
Sada, M ;
Goto, R ;
Takeshima, S ;
Aida, Y ;
Iwanaga, T ;
Fujimura, N ;
Suzuki, Y ;
Gojobori, T ;
Inoko, H .
IMMUNOGENETICS, 2003, 55 (09) :583-593
[8]
[Anonymous], SWINE BIOMEDICAL RES
[9]
SERUM FRUCTOSAMINE CONCENTRATION AS MEASURE OF BLOOD-GLUCOSE CONTROL IN TYPE-I (INSULIN DEPENDENT) DIABETES-MELLITUS [J].
BAKER, JR ;
METCALF, PA ;
HOLDAWAY, IM ;
JOHNSON, RN .
BRITISH MEDICAL JOURNAL, 1985, 290 (6465) :352-355
[10]
CLINICAL USEFULNESS OF ESTIMATION OF SERUM FRUCTOSAMINE CONCENTRATION AS A SCREENING-TEST FOR DIABETES-MELLITUS [J].
BAKER, JR ;
OCONNOR, JP ;
METCALF, PA ;
LAWSON, MR ;
JOHNSON, RN .
BRITISH MEDICAL JOURNAL, 1983, 287 (6396) :863-867